You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers found that functional assays could improve the classification of cystic fibrosis-related missense variants with variable disease expressivity.
Owlstone will give AstraZeneca access to its Breath Biopsy Services to identify breath-based biomarkers for stratifying and treating asthma and COPD patients.
The funding will support various projects and research centers that are advancing precision medicine and genomic technology development.
The new instrument has higher throughput than competing systems, while the flu test boasts enhanced sensitivity and protection against seasonal drift.
The panel is the first offering in an anticipated menu of clinical microbiology and infectious disease tests.
Penn bioinformaticians are testing REALGAR, an application to simplify searches of GWAS, WGS, RNA-seq, and other test results for wet-lab researchers.
The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.
While point-of-care molecular testing of patients with respiratory illness wasn't associated with lower antibiotic use, patients tested had shorter drug courses.
The firm said that its test is the first on the market to detect RSV infection at the point of care in 13 minutes or less.
A team of researchers in the UK used a two-stage approach to tie the rare variants to disease risk.
Bio-Techne will provide a bioanalytical assay for the group to assess and validate as a bioanalytical method for clinical trial recruitment.
The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.
The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.
In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.
President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.